LifeVantage to Participate in the 27th Annual ICR Conference
LifeVantage (LFVN), a health and wellness company focusing on cellular-level health products, has announced its participation in the upcoming 27th Annual ICR Conference in Orlando, FL. The company will be represented by President and CEO Steve Fife and CFO Carl Aure, who are scheduled to present on Monday, January 13, 2025, at 10:30 a.m. Eastern Time.
Investors and interested parties can access the presentation through a webcast available on the News & Events section of LifeVantage's Investor Relations website. The conference is set to run from January 13-15, 2025.
LifeVantage (LFVN), un'azienda specializzata in salute e benessere focalizzata su prodotti per la salute a livello cellulare, ha annunciato la sua partecipazione alla 27ª Conferenza Annuale ICR che si terrà a Orlando, FL. L'azienda sarà rappresentata da Steve Fife, Presidente e CEO e Carl Aure, CFO, che sono programmati per presentare lunedì 13 gennaio 2025, alle 10:30 ora orientale.
Gli investitori e le parti interessate possono accedere alla presentazione tramite un webcast disponibile nella sezione Notizie & Eventi del sito web delle Relazioni con gli Investitori di LifeVantage. La conferenza si svolgerà dal 13 al 15 gennaio 2025.
LifeVantage (LFVN), una empresa de salud y bienestar enfocada en productos de salud a nivel celular, ha anunciado su participación en la 27ª Conferencia Anual ICR en Orlando, FL. La empresa estará representada por Steve Fife, Presidente y CEO y Carl Aure, CFO, quienes están programados para presentar el lunes 13 de enero de 2025, a las 10:30 a.m. hora del Este.
Los inversores y partes interesadas pueden acceder a la presentación a través de un webcast disponible en la sección de Noticias y Eventos del sitio web de Relaciones con Inversores de LifeVantage. La conferencia se llevará a cabo del 13 al 15 de enero de 2025.
LifeVantage (LFVN)는 세포 수준의 건강 제품에 중점을 둔 건강 및 웰니스 회사로, 플로리다주 올랜도에서 열리는 제27회 연례 ICR 컨퍼런스에 참석한다고 발표했습니다. 이 회사는 스티브 파이프, 사장 겸 CEO와 칼 아우레, CFO가 참석하여 2025년 1월 13일 월요일 오후 10시 30분 동부 표준시에 발표할 예정입니다.
투자자 및 관심 있는 당사자는 LifeVantage 투자자 관계 웹사이트의 뉴스 및 이벤트 섹션에서 제공되는 웹캐스트를 통해 발표에 접근할 수 있습니다. 컨퍼런스는 2025년 1월 13일부터 15일까지 진행됩니다.
LifeVantage (LFVN), une entreprise de santé et de bien-être axée sur des produits de santé au niveau cellulaire, a annoncé sa participation à la 27e Conférence Annuelle ICR à Orlando, FL. L'entreprise sera représentée par Steve Fife, Président et CEO et Carl Aure, CFO, qui sont programmés pour présenter le lundi 13 janvier 2025, à 10h30 heure de l'Est.
Les investisseurs et les parties intéressées peuvent accéder à la présentation par le biais d'un webinaire disponible dans la section Nouvelles & Événements du site de Relations avec les Investisseurs de LifeVantage. La conférence se déroulera du 13 au 15 janvier 2025.
LifeVantage (LFVN), ein Unternehmen für Gesundheit und Wellness, das sich auf Produkte für die Zellgesundheit konzentriert, hat seine Teilnahme an der 27. Jahreskonferenz ICR in Orlando, FL, angekündigt. Das Unternehmen wird vertreten durch Steve Fife, Präsident und CEO und Carl Aure, CFO, die am Montag, den 13. Januar 2025, um 10:30 Uhr Eastern Time präsentieren werden.
Investoren und Interessierte können auf die Präsentation über ein Webcast zugreifen, der im Bereich Nachrichten & Veranstaltungen auf der Website der Investor Relations von LifeVantage verfügbar ist. Die Konferenz findet vom 13. bis 15. Januar 2025 statt.
- None.
- None.
SALT LAKE CITY, Jan. 06, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer, and Carl Aure, Chief Financial Officer, will participate in the 27th Annual ICR Conference to be held January 13-15, 2025 in Orlando, FL.
Mr. Fife and Mr. Aure will present at approximately 10:30 a.m. Eastern Time on Monday, January 13, 2025. A webcast of their presentation will be accessible on the News & Events section of the Company’s Investor Relations website at https://lifevantage.gcs-web.com/ or directly here.
About LifeVantage Corporation
LifeVantage Corporation® (Nasdaq: LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our products work with your unique biology and help your body make what it needs for health. The line of scientifically validated activators includes the flagship Protandim® family of products, TrueScience® Liquid Collagen, the newest MindBody GLP-1 System™, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System™, as well as AXIO® nootropic energy drink mixes, the full TrueScience® line of skin and hair care products, and Petandim®, a pet supplement formulated to combat oxidative stress in dogs. Our independent Consultants sell our products to Customers and share the business opportunity with entrepreneurs seeking to begin their own sales business. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com.
Investor Relations Contact:
Reed Anderson, ICR
(646) 277-1260
reed.anderson@icrinc.com
FAQ
When is LifeVantage (LFVN) presenting at the 2025 ICR Conference?
How can investors watch LifeVantage's (LFVN) ICR Conference presentation?
Which LifeVantage (LFVN) executives are presenting at the 2025 ICR Conference?
What is the duration of the 2025 ICR Conference where LFVN is presenting?
